These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 8201547)
41. Dissolution of theophylline from film-coated slow release mini-tablets in various dissolution media. Fassihi AR; Munday DL J Pharm Pharmacol; 1989 Jun; 41(6):369-72. PubMed ID: 2570830 [TBL] [Abstract][Full Text] [Related]
42. Preparation and characterization of alginate/chitosan formulations for ciprofloxacin-controlled delivery. Kyzioł A; Mazgała A; Michna J; Regiel-Futyra A; Sebastian V J Biomater Appl; 2017 Aug; 32(2):162-174. PubMed ID: 28649925 [TBL] [Abstract][Full Text] [Related]
43. pH-independent sustained release matrix tablet containing doxazosin mesylate: effect of citric acid. Cha KH; Tran TH; Kim MS; Kim JS; Park HJ; Park J; Cho W; Hwang SJ Arch Pharm Res; 2010 Dec; 33(12):2003-9. PubMed ID: 21191766 [TBL] [Abstract][Full Text] [Related]
44. Preparation of Carbopol/chitosan interpolymer complex as a controlled release tablet matrix; effect of complex formation medium on drug release characteristics. Lee MH; Chun MK; Choi HK Arch Pharm Res; 2008 Jul; 31(7):932-7. PubMed ID: 18704338 [TBL] [Abstract][Full Text] [Related]
45. Sustained release of a water-soluble drug from alginate matrix tablets prepared by wet granulation method. Mandal S; Basu SK; Sa B AAPS PharmSciTech; 2009; 10(4):1348-56. PubMed ID: 19911286 [TBL] [Abstract][Full Text] [Related]
46. Sustained release tablets based on chitosan and carboxymethylcellulose sodium. Inouye K; Machida Y; Nagai T Drug Des Deliv; 1987 May; 1(4):297-305. PubMed ID: 3509339 [TBL] [Abstract][Full Text] [Related]
47. Preparation and evaluation of beads made of different calcium alginate compositions for oral sustained release of tiaramide. Fathy M; Safwat SM; el-Shanawany SM; Shawky Tous S; Otagiri M Pharm Dev Technol; 1998 Aug; 3(3):355-64. PubMed ID: 9742556 [TBL] [Abstract][Full Text] [Related]
48. Study of the prolonged release of theopylline from polymeric matrices based on grafted chitosan with acrylamide. Tapia C; Costa E; Terraza C; Munita AM; Yazdani-Pedram M Pharmazie; 2002 Nov; 57(11):744-9. PubMed ID: 12611277 [TBL] [Abstract][Full Text] [Related]
49. In vitro/in vivo evaluation of HPMC/alginate based extended-release matrix tablets of cefpodoxime proxetil. Mujtaba A; Kohli K Int J Biol Macromol; 2016 Aug; 89():434-41. PubMed ID: 27155235 [TBL] [Abstract][Full Text] [Related]
50. Evaluation of hydrophilic matrix tablets based on Carbopol(®) 971P and low-viscosity sodium alginate for pH-independent controlled drug release. Al-Zoubi NM; AlKhatib HS; Obeidat WM Drug Dev Ind Pharm; 2011 Jul; 37(7):798-808. PubMed ID: 21247372 [TBL] [Abstract][Full Text] [Related]
51. Gastro-resistant characteristics of GRAS-grade enteric coatings for pharmaceutical and nutraceutical products. Czarnocka JK; Alhnan MA Int J Pharm; 2015; 486(1-2):167-74. PubMed ID: 25796126 [TBL] [Abstract][Full Text] [Related]
52. Synthesis of iron-crosslinked chitosan succinate and iron-crosslinked hydroxamated chitosan succinate and their in vitro evaluation as potential matrix materials for oral theophylline sustained-release beads. Aiedeh K; Taha MO Eur J Pharm Sci; 2001 May; 13(2):159-68. PubMed ID: 11297900 [TBL] [Abstract][Full Text] [Related]
53. Floating tablets for controlled release of ofloxacin via compression coating of hydroxypropyl cellulose combined with effervescent agent. Qi X; Chen H; Rui Y; Yang F; Ma N; Wu Z Int J Pharm; 2015 Jul; 489(1-2):210-7. PubMed ID: 25956047 [TBL] [Abstract][Full Text] [Related]
54. Buoyant sustained release tablets based on chitosan. Inouye K; Machida Y; Sannan T; Nagai T Drug Des Deliv; 1988 Feb; 2(3):165-75. PubMed ID: 2855572 [TBL] [Abstract][Full Text] [Related]
55. Pharmacokinetics of a novel nifedipine and pH-sensitive N-succinyl chitosan/alginate hydrogel bead in rabbits. Zhu XJ; Yuan W; Li P; Liu X; He JQ Drug Dev Ind Pharm; 2010 Dec; 36(12):1463-8. PubMed ID: 20704460 [TBL] [Abstract][Full Text] [Related]
56. Design and characterization of calcium-free in-situ gel formulation based on sodium alginate and chitosan. Belhadji L; HadjSadok A; Moulai-Mostefa N Drug Dev Ind Pharm; 2018 Apr; 44(4):662-669. PubMed ID: 29172753 [TBL] [Abstract][Full Text] [Related]
57. [Hypoglycemic effect of polysaccharide-coated insulin liposomes after oral administration in mice]. Wu ZH; Ping QN; Lai JM; Wei Y Yao Xue Xue Bao; 2003 Feb; 38(2):138-42. PubMed ID: 12778751 [TBL] [Abstract][Full Text] [Related]
58. Design of nateglinide controlled release tablet containing erosion matrix tablet and multiple administration study in normal beagle dogs. Makino C; Sakai H; Okano A; Yabuki A Chem Pharm Bull (Tokyo); 2009 Sep; 57(9):907-13. PubMed ID: 19721250 [TBL] [Abstract][Full Text] [Related]
59. In vivo evaluation of two new sustained release formulations elaborated by one-step melt granulation: level A in vitro-in vivo correlation. Ochoa L; Igartua M; Hernández RM; Solinís MA; Gascón AR; Pedraz JL Eur J Pharm Biopharm; 2010 Jun; 75(2):232-7. PubMed ID: 20159037 [TBL] [Abstract][Full Text] [Related]
60. Preparation and characterization of melatonin-loaded stearyl alcohol microspheres. Lee BJ; Choe JS; Kim CK J Microencapsul; 1998; 15(6):775-87. PubMed ID: 9818955 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]